Gelonghui, April 30, 丨 Tong Ren Tang Chinese Medicine (03613.HK) announced that the company recently received the “Certificate of Registration for Proprietary Chinese Medicines” issued by the Hong Kong Traditional Chinese Medicine Administration, permitting the sale of “Angelica Supplementation Granules [Tong Ren Tang]” in Hong Kong. The relevant information notice is as follows: Drug Name: Angelica Blood Supplementation Granules [Tong Ren Tang]; Registered Holder and Address: Beijing Tong Ren Tang Sinopharm Co., Ltd., No. 3, Da Jing Street, Tai Po Industrial Estate, New Territories, Hong Kong; registration number: HKC-18604; certificate validity period: until April 25, 2029.

“Angelica Blood Supplementation Granules [Tong Ren Tang]” is used to nourish qi and produce blood, and is used for symptoms of hypothermia. I saw that my skin was hot and red, thirsty and wanted to drink, my pulse was large and empty, and I was unable to press again. As of the date of this announcement, the company has invested a total of approximately HK$800,000 in R&D of “Angelica Blood Supplements [Tong Ren Tang]” (the amount has not been audited), and the product has not yet been put on the market.

This time, after the company obtained a proprietary Chinese medicine registration certificate issued by the Hong Kong Traditional Chinese Medicine Administration, the “Angelica Blood Supplementation Granules [Tong Ren Tang]” produced by the company can be sold in Hong Kong, which helps to enrich the company's product line and facilitate the company's market expansion. The acquisition of the above registration certificate will not have a significant impact on the company's production, operation and performance for the time being. Pharmaceutical sales are easily affected by factors such as changes in the Hong Kong region's policy environment, exchange rate fluctuations, and market competition.